[IMRX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[IMRX] Immuneering Corporation
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -3.33%
YoY- -0.75%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 -94,419 0 94,419 0 0 -
PBT -14,080 -14,308 -15,084 -12,595 -12,189 -13,604 -13,246 4.15%
Tax -0 -0 -755 -13,912,372 -1,139 -1,075,403 -740 -
NP -14,080 -14,308 -15,083 -12,595 -12,189 1,061,799 -12,506 8.23%
Tax Rate - - - - - - - -
Total Cost 14,080 14,308 -79,336 12,595 106,608 -1,061,799 12,506 8.23%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 15.98 0.00 -12.91 0.00 -2,742,434.65 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.47 -0.49 -0.52 -0.43 -0.43 40.16 -0.47 0.00%
EPS Diluted -0.47 -0.49 -0.52 -0.43 -0.43 40.16 -0.47 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.